Mandate

Vinge advises Astrego Diagnostics AB in conjunction with capital procurement

January 29, 2020 M&A

Vinge has advised Astrego Diagnostics AB in connection with the investment in the company by the Japanese company Sysmex Corporation, which has acquired approximately 25% of the shares in the company.

Astrego develops a ground‑breaking technology for characterization of antibiotic‑sensitivity. The first product gives doctors a patient specific diagnostic tool for urinary infections.

Vinge’s team consisted of Johan Winnerblad, Kristina Ekberg and Viktoria Owetz Leyva.

Related

Vinge advises TSG on the acquisition of Processkontroll GT

TSG, a European leader in technical services for sustainable mobility solutions and critical energy infrastructure, has acquired Processkontroll GT, a specialist in compressed and liquid gas infrastructure.
June 01, 2026

Vinge has advised Nordion Energi AB in connection with the acquisition of shares in Kalmar Energi

Nordion Energi acquires E.ON Sverige AB’s entire stake in Kalmar Energi and in connection with the completion of such, divest Kalmar Energi’s electricity retail business to Siljansvik AB (publ).
May 29, 2026

Vinge advises Latour on the sale of shares in ASSA ABLOY and Securitas, amounting to SEK 2.5 billion in each company

Vinge has advised Investmentaktiebolaget Latour (publ) in connection with the sale of parts of its shareholdings in ASSA ABLOY and Securitas for a total value of SEK 5 billion.
May 27, 2026